FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014306009> ?p ?o ?g. }

• W2014306009 endingPage "591" @default.
• W2014306009 startingPage "580" @default.
• W2014306009 abstract "Background Evidence suggests that nebulized lidocaine is beneficial in asthma therapy, but to what extent and the mechanisms underlying this effect remain poorly understood. The aim of this study was to assess the impact of lidocaine treatment using a murine model of allergic asthma characterized by expression of pivotal features of the disease: inflammation, mucus production, and lung remodeling. Methods A/J mice sensitized with ovalbumin were treated with inhaled lidocaine or vehicle immediately after ovalbumin intranasal challenges. Lung function, total and differential leukocytes in bronchoalveolar lavage fluid, peribronchial eosinophil density, interleukin (IL)-4, IL-5 and eotaxin-1 levels, epithelial mucus, collagen, extracellular-matrix deposition, matrix metalloproteinase-9 activity, and GATA-3 expression were evaluated. Between five and eight animals per group were used. Results Inhaled lidocaine inhibited ovalbumin-induced airway hyperreactivity to methacholine, and accumulation of lymphocytes, neutrophils, and eosinophils in bronchoalveolar lavage fluid 24 h after the last allergen provocation. Lidocaine administration also prevented other pathophysiological changes triggered by ovalbumin in lung tissue, including peribronchial eosinophil and neutrophil infiltration, subepithelial fibrosis, increased content of collagen and mucus, matrix metalloproteinase-9 activity, and increased levels of IL-4, IL-5, IL-13, and eotaxin-1. Furthermore, inhaled lidocaine inhibited lung tissue GATA-3 expression in ovalbumin-challenged mice. We also demonstrated that lidocaine inhibited the expression of GATA-3 in ovalbumin-stimulated T cells in vitro. Conclusions Inhaled lidocaine prevents eosinophilic inflammation, overproduction of mucus, and peribronchial fibrosis in a murine model of asthma, and impaired airway hyperreactivity, possibly by inhibiting allergen-evoked GATA-3 expression and the subsequent up-regulation of proinflammatory cytokines and chemokines." @default.
• W2014306009 created "2016-06-24" @default.
• W2014306009 creator A5007014233 @default.
• W2014306009 creator A5011187647 @default.
• W2014306009 creator A5015299645 @default.
• W2014306009 creator A5022261651 @default.
• W2014306009 creator A5034013632 @default.
• W2014306009 creator A5045088469 @default.
• W2014306009 creator A5045806624 @default.
• W2014306009 creator A5048654962 @default.
• W2014306009 creator A5055225175 @default.
• W2014306009 creator A5078799744 @default.
• W2014306009 creator A5085039459 @default.
• W2014306009 creator A5087557108 @default.
• W2014306009 creator A5090360981 @default.
• W2014306009 date "2012-09-01" @default.
• W2014306009 modified "2023-10-01" @default.
• W2014306009 title "Nebulized Lidocaine Prevents Airway Inflammation, Peribronchial Fibrosis, and Mucus Production in a Murine Model of Asthma" @default.
• W2014306009 cites W1504741434 @default.
• W2014306009 cites W1522122289 @default.
• W2014306009 cites W1582822353 @default.
• W2014306009 cites W1605768991 @default.
• W2014306009 cites W1905974983 @default.
• W2014306009 cites W1926391481 @default.
• W2014306009 cites W1966288602 @default.
• W2014306009 cites W1979859802 @default.
• W2014306009 cites W1984250684 @default.
• W2014306009 cites W1984642806 @default.
• W2014306009 cites W1996043249 @default.
• W2014306009 cites W1999705022 @default.
• W2014306009 cites W2004830764 @default.
• W2014306009 cites W2006386088 @default.
• W2014306009 cites W2010093550 @default.
• W2014306009 cites W2018466568 @default.
• W2014306009 cites W2025029128 @default.
• W2014306009 cites W2027699993 @default.
• W2014306009 cites W2030057061 @default.
• W2014306009 cites W2030931125 @default.
• W2014306009 cites W2042504878 @default.
• W2014306009 cites W2045404555 @default.
• W2014306009 cites W2046660452 @default.
• W2014306009 cites W2047672740 @default.
• W2014306009 cites W2057169976 @default.
• W2014306009 cites W2065348891 @default.
• W2014306009 cites W2073983790 @default.
• W2014306009 cites W2105973978 @default.
• W2014306009 cites W2109920251 @default.
• W2014306009 cites W2110204263 @default.
• W2014306009 cites W2110206778 @default.
• W2014306009 cites W2110681571 @default.
• W2014306009 cites W2115024557 @default.
• W2014306009 cites W2126515688 @default.
• W2014306009 cites W2131733306 @default.
• W2014306009 cites W2135536194 @default.
• W2014306009 cites W2143371668 @default.
• W2014306009 cites W2145051681 @default.
• W2014306009 cites W2159219764 @default.
• W2014306009 cites W2343236106 @default.
• W2014306009 cites W237110708 @default.
• W2014306009 cites W2396666625 @default.
• W2014306009 cites W2419323443 @default.
• W2014306009 cites W2094436720 @default.
• W2014306009 doi "https://doi.org/10.1097/aln.0b013e31826687d5" @default.
• W2014306009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22846675" @default.
• W2014306009 hasPublicationYear "2012" @default.
• W2014306009 type Work @default.
• W2014306009 sameAs 2014306009 @default.
• W2014306009 citedByCount "43" @default.
• W2014306009 countsByYear W20143060092012 @default.
• W2014306009 countsByYear W20143060092013 @default.
• W2014306009 countsByYear W20143060092014 @default.
• W2014306009 countsByYear W20143060092015 @default.
• W2014306009 countsByYear W20143060092016 @default.
• W2014306009 countsByYear W20143060092017 @default.
• W2014306009 countsByYear W20143060092018 @default.
• W2014306009 countsByYear W20143060092019 @default.
• W2014306009 countsByYear W20143060092020 @default.
• W2014306009 countsByYear W20143060092022 @default.
• W2014306009 countsByYear W20143060092023 @default.
• W2014306009 crossrefType "journal-article" @default.
• W2014306009 hasAuthorship W2014306009A5007014233 @default.
• W2014306009 hasAuthorship W2014306009A5011187647 @default.
• W2014306009 hasAuthorship W2014306009A5015299645 @default.
• W2014306009 hasAuthorship W2014306009A5022261651 @default.
• W2014306009 hasAuthorship W2014306009A5034013632 @default.
• W2014306009 hasAuthorship W2014306009A5045088469 @default.
• W2014306009 hasAuthorship W2014306009A5045806624 @default.
• W2014306009 hasAuthorship W2014306009A5048654962 @default.
• W2014306009 hasAuthorship W2014306009A5055225175 @default.
• W2014306009 hasAuthorship W2014306009A5078799744 @default.
• W2014306009 hasAuthorship W2014306009A5085039459 @default.
• W2014306009 hasAuthorship W2014306009A5087557108 @default.
• W2014306009 hasAuthorship W2014306009A5090360981 @default.
• W2014306009 hasBestOaLocation W20143060091 @default.
• W2014306009 hasConcept C126322002 @default.
• W2014306009 hasConcept C142724271 @default.
• W2014306009 hasConcept C147483822 @default.
• W2014306009 hasConcept C18903297 @default.

• next